Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$2.86 - $3.61 $11,222 - $14,165
-3,924 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$2.02 - $3.02 $2,834 - $4,237
-1,403 Reduced 26.34%
3,924 $8,000
Q1 2020

May 14, 2020

SELL
$1.82 - $3.87 $4,151 - $8,827
-2,281 Reduced 29.98%
5,327 $13,000
Q1 2019

May 15, 2019

BUY
$2.54 - $4.02 $3,159 - $5,000
1,244 Added 19.55%
7,608 $21,000
Q2 2018

Aug 10, 2018

SELL
$5.06 - $6.78 $7,412 - $9,932
-1,465 Reduced 18.71%
6,364 $33,000
Q1 2018

May 17, 2018

SELL
$5.43 - $8.36 $19,900 - $30,639
-3,665 Reduced 31.89%
7,829 $43,000
Q4 2017

Feb 13, 2018

BUY
$8.15 - $10.55 $93,676 - $121,261
11,494
11,494 $95,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $36.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.